Jakafi 10 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FFBM9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $78,646
Award facts
- Contract value 100% obligated
- $78,646.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm fixed-price delivery order valued at $78,646.23 to DMS Pharmaceutical Group Inc. for 60-count bottles of Jakafi 10 mg tablets, with an ultimate completion date of November 25, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded this delivery order without a set-aside designation, demonstrating its competitive capability in unrestricted federal procurement. The order will be fulfilled from the vendor's Park Ridge location and supports the Department of Defense's pharmaceutical supply requirements.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, designated as SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. That IDC, awarded on November 13, 2025, carries a $499.9 million ceiling value and extends through December 31, 2036, positioning DMS Pharmaceutical Group as a regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy. The IDC authorizes DLA to issue delivery orders for a comprehensive range of pharmaceutical products and medical consumables to support military healthcare facilities worldwide, with this Jakafi order exemplifying the specialized pharmaceutical requirements fulfilled through the program.
Quick answers
Who was awarded contract SPE2DR26FFBM9?
SPE2DR26FFBM9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26FFBM9 worth?
The government has obligated $78,646 on SPE2DR26FFBM9.
Is contract SPE2DR26FFBM9 an order under another contract?
Yes. SPE2DR26FFBM9 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBM9 competed?
The extent of competition for SPE2DR26FFBM9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award